Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 1
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Growth suppression by MYC inhibition in small cell lung cancer cells with TP53 and RB1 inactivation

  • Fiorentino, Francesco Paolo
  • Tokgün, Elvan
  • Solé-Sánchez, Sònia
  • Giampaolo, Sabrina
  • Tokgün, Onur
  • Jauset González, Toni
  • Kohno, Takashi|||0000-0002-5371-706X
  • Perucho, Manuel|||0000-0002-2169-2662
  • Soucek, Laura|||0000-0002-4750-7971
  • Yokota, Jun|||0000-0001-6010-6294
Small cell lung cancer (SCLC) is the most aggressive type of lung cancer with high mortality. One of the MYC family genes, MYC, MYCL or MYCN, is amplified in ~20% of the SCLCs; therefore, MYC proteins are potential therapeutic targets in SCLC patients. We investigated the therapeutic impact of Omomyc, a MYC dominant negative, in a panel of SCLC cell lines. Strikingly, Omomyc suppressed the growth of all tested cell lines by inducing cell cycle arrest and/or apoptosis. Induction of G1 arrest by Omomyc was found to be dependent on the activation of CDKN1A, in part, through the TP73 pathway. Our results strongly indicate that SCLC cells carrying amplification of MYC, MYCL or MYCN are addicted to MYC function, suggesting that MYC targeting would be an efficient therapeutic option for SCLC patients.